Shahnam A - Search Results

1

Can cancer registries show whether treatment is contributing to survival increases for melanoma of the skin at a population level?

Shahnam A, Roder DM, Tracey EA, Neuhaus SJ, Brown MP, Sorich MJ. Shahnam A, et al. J Eval Clin Pract. 2014 Feb;20(1):74-80. doi: 10.1111/jep.12081. Epub 2013 Sep 23. J Eval Clin Pract. 2014. PMID: 24112148

2

Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis.

Shahnam A, Ridha Z, Wiese MD, Kichenadasse G, Sorich MJ. Shahnam A, et al. Pharmacogenomics. 2016 Oct;17(15):1725-1732. doi: 10.2217/pgs-2016-0102. Epub 2016 Sep 16. Pharmacogenomics. 2016. PMID: 27636246

3

Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data.

Hopkins AM, Shahnam A, Zhang S, Karapetis CS, Rowland A, Sorich MJ. Hopkins AM, et al. Among authors: shahnam a. Cancer Biol Med. 2019 May;16(2):341-349. doi: 10.20892/j.issn.2095-3941.2018.0474. Cancer Biol Med. 2019. PMID: 31516754 Free PMC article.

4

The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy.

Badaoui S, Shahnam A, McKinnon RA, Abuhelwa AY, Sorich MJ, Hopkins AM. Badaoui S, et al. Among authors: shahnam a. Transl Lung Cancer Res. 2022 Mar;11(3):432-439. doi: 10.21037/tlcr-21-938. Transl Lung Cancer Res. 2022. PMID: 35399575 Free PMC article.

5

Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer.

Modi ND, Danell NO, Perry RNA, Abuhelwa AY, Rathod A, Badaoui S, McKinnon RA, Haseloff M, Shahnam A, Swain SM, Welslau M, Sorich MJ, Hopkins AM. Modi ND, et al. Among authors: shahnam a. ESMO Open. 2022 Jun;7(3):100475. doi: 10.1016/j.esmoop.2022.100475. Epub 2022 Apr 28. ESMO Open. 2022. PMID: 35490579 Free PMC article.

6

Time to deterioration of patient-reported outcomes as a surrogate of overall survival: a meta-analysis.

Shahnam A, Nindra U, Desai J, Hui R, Buyse M, Hopkins AM, Sorich MJ. Shahnam A, et al. J Natl Cancer Inst. 2023 Dec 6;115(12):1475-1482. doi: 10.1093/jnci/djad152. J Natl Cancer Inst. 2023. PMID: 37540222

7

Elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poorer progression-free survival in unresectable stage III NSCLC treated with consolidation durvalumab.

Nindra U, Shahnam A, Stevens S, Pal A, Nagrial A, Lee J, Yip PY, Adam T, Boyer M, Kao S, Bray V. Nindra U, et al. Among authors: shahnam a. Thorac Cancer. 2022 Nov;13(21):3058-3062. doi: 10.1111/1759-7714.14646. Epub 2022 Sep 16. Thorac Cancer. 2022. PMID: 36111516 Free PMC article.

8

Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis.

Nindra U, Shahnam A, Mahon KL. Nindra U, et al. Among authors: shahnam a. Asia Pac J Clin Oncol. 2022 Feb;18(1):7-12. doi: 10.1111/ajco.13552. Epub 2021 Feb 19. Asia Pac J Clin Oncol. 2022. PMID: 33609014 Review.

9

Prognostic Utility of CDX2 and PD-L1 in Rectal Cancer.

Shahnam A, Paver E, Nguyen B, Fadia M, Ali S. Shahnam A, et al. Appl Immunohistochem Mol Morphol. 2020 Jul;28(6):e53. doi: 10.1097/PAI.0000000000000752. Appl Immunohistochem Mol Morphol. 2020. PMID: 31166198 No abstract available.

10

Growing Teratoma Syndrome in the Setting of Sarcoidosis: A Case Report and Literature Review.

Shahnam A, Sayer R, Herbst U, Sharma R, Yoon WH, Dinihan T, Gao B. Shahnam A, et al. Curr Oncol. 2022 Jun 7;29(6):4148-4154. doi: 10.3390/curroncol29060331. Curr Oncol. 2022. PMID: 35735440 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters